Search

Author/Creator Slee, Mark

32. Ribosomal protein S6 mRNA is a biomarker upregulated in multiple sclerosis, downregulated by interferon treatment, and affected by season. (May 2014)

Authors:
Parnell, Grant P; Gatt, Prudence N; McKay, Fiona C; Schibeci, Stephen; Krupa, Malgorzata; Powell, Joseph E; Visscher, Peter M; Montgomery, Grant W; Lechner-Scott, Jeannette; Broadley, Simon; Liddle, Christopher; Slee, Mark; Vucic, Steve; Stewart, Graeme J; Booth, David R
Journal:
Multiple sclerosis
Issue:
Volume 20:Number 6(2014)
Page Start:
675
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

33. Risk of relapse phenotype recurrence in multiple sclerosis. (October 2014)

Authors:
Kalincik, Tomas; Buzzard, Katherine; Jokubaitis, Vilija; Trojano, Maria; Duquette, Pierre; Izquierdo, Guillermo; Girard, Marc; Lugaresi, Alessandra; Grammond, Pierre; Grand'Maison, Francois; Oreja-Guevara, Celia; Boz, Cavit; Hupperts, Raymond; Petersen, Thor; Giuliani, Giorgio; Iuliano, Gerardo; ...
Journal:
Multiple sclerosis
Issue:
Volume 20:Number 11(2014)
Page Start:
1511
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

34. Risk of secondary progressive multiple sclerosis: A longitudinal study. (January 2020)

Authors:
Fambiatos, Adam; Jokubaitis, Vilija; Horakova, Dana; Kubala Havrdova, Eva; Trojano, Maria; Prat, Alexandre; Girard, Marc; Duquette, Pierre; Lugaresi, Alessandra; Izquierdo, Guillermo; Grand'Maison, Francois; Grammond, Pierre; Sola, Patrizia; Ferraro, Diana; Alroughani, Raed; Terzi, Murat; Huppert...
Journal:
Multiple sclerosis
Issue:
Volume 26:Number 1(2020)
Page Start:
79
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

35. Seasonal variation of relapse rate in multiple sclerosis is latitude dependent. Issue 6 (20th October 2014)

Authors:
Spelman, Tim; Gray, Orla; Trojano, Maria; Petersen, Thor; Izquierdo, Guillermo; Lugaresi, Alessandra; Hupperts, Raymond; Bergamaschi, Roberto; Duquette, Pierre; Grammond, Pierre; Giuliani, Giorgio; Boz, Cavit; Verheul, Freek; Oreja‐Guevara, Celia; Barnett, Michael; Grand'Maison, Francois; Edite R...
Journal:
Annals of neurology
Issue:
Volume 76:Issue 6(2014:Dec.)
Page Start:
880
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

36. Switch to natalizumab versus fingolimod in active relapsing–remitting multiple sclerosis. Issue 3 (17th January 2015)

Authors:
Kalincik, Tomas; Horakova, Dana; Spelman, Tim; Jokubaitis, Vilija; Trojano, Maria; Lugaresi, Alessandra; Izquierdo, Guillermo; Rozsa, Csilla; Grammond, Pierre; Alroughani, Raed; Duquette, Pierre; Girard, Marc; Pucci, Eugenio; Lechner‐Scott, Jeannette; Slee, Mark; Fernandez‐Bolanos, Ricardo; Grand...
Journal:
Annals of neurology
Issue:
Volume 77:Issue 3(2015:Mar.)
Page Start:
425
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

37. The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis. (April 2016)

Authors:
Warrender-Sparkes, Matthew; Spelman, Tim; Izquierdo, Guillermo; Trojano, Maria; Lugaresi, Alessandra; Grand'Maison, François; Havrdova, Eva; Horakova, Dana; Boz, Cavit; Oreja-Guevara, Celia; Alroughani, Raed; Iuliano, Gerardo; Duquette, Pierre; Girard, Marc; Terzi, Murat; Hupperts, Raymond; Gramm...
Journal:
Multiple sclerosis
Issue:
Volume 22:Number 4(2016)
Page Start:
520
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

38. The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry. Issue 3 (28th December 2011)

Authors:
Hughes, Stella; Spelman, Timothy; Trojano, Maria; Lugaresi, Alessandra; Izquierdo, Guillermo; Grand'Maison, Francois; Duquette, Pierre; Girard, Marc; Grammond, Pierre; Oreja-Guevara, Celia; Hupperts, Raymond; Boz, Cavit; Bergamaschi, Roberto; Giuliani, Giorgio; Rio, Maria Edite; Lechner-Scott, Je...
Journal:
Journal of neurology, neurosurgery and psychiatry
Issue:
Volume 83:Issue 3(2012)
Page Start:
305
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

39. Timing of high-efficacy disease modifying therapies for relapsing-remitting multiple sclerosis. Issue 5 (8th May 2017)

Authors:
Merkel, Bernd; Jokubaitis, Vilija; Spelman, Tim; Lechner-Scott, Jeannette; McCombe, Pamela; Slee, Mark; Vucic, Steve; Skibina, Olga; Barnett, Michael; Hodgkinson, Suzanne; Butzkueven, Helmut; Kalincik, Tomas
Journal:
Journal of neurology, neurosurgery and psychiatry
Issue:
Volume 88:Issue 5(2017)
Page Start:
e1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

40. Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study. Issue 4 (April 2017)

Authors:
Kalincik, Tomas; Brown, J William L; Robertson, Neil; Willis, Mark; Scolding, Neil; Rice, Claire M; Wilkins, Alastair; Pearson, Owen; Ziemssen, Tjalf; Hutchinson, Michael; McGuigan, Christopher; Jokubaitis, Vilija; Spelman, Tim; Horakova, Dana; Havrdova, Eva; Trojano, Maria; Izquierdo, Guillermo;...
Journal:
Lancet neurology
Issue:
Volume 16:Issue 4(2017:Apr.)
Page Start:
271
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗